Archives of Gynecology and Obstetrics

, Volume 255, Supplement 2, pp S379–S380 | Cite as

Present status and potential role of high-dose adjuvant chemotherapy in breast cancer with poor prognosis

  • B. Thürlimann
Seminar Über Neues Aus Der Gynäkologie Und Geburtshilfe
  • 16 Downloads

Keywords

Public Health Breast Cancer Poor Prognosis Potential Role Adjuvant Chemotherapy 

References

  1. 1.
    Peters WP, Ross M, Vredenurgh JJ et al. (1993) High dose chemotherapy and autologous bone marrow support as consolidation after standard dose adjuvant therapy for high risk primary breast cancer. J Clin Oncol 11:1132–1143PubMedGoogle Scholar
  2. 2.
    Fisher B, Wickerham DL, Redmont C (1992) Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer. Semin Oncol 19:263–277PubMedGoogle Scholar
  3. 3.
    Sheriden WP, Begly CG, Ludner CA (1992) Effect of peripheral blood progenitor cells mobilized by philcastin (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 339:640–644Google Scholar
  4. 4.
    Gianni AM, Siena S, Bregni M, et al. (1992) Growth factor supported high dose sequential adjuvant chemotherapy in breast cancer with ≥10 positive nodes. Proc ASCO 11, abstract 68Google Scholar
  5. 5.
    Focan C, Andrien J, Closen M, et al. (1993) Dose response relationship of epirubicine based first line chemotherapy for advanced breast cancer: a prospective randomized trial. J Clin Oncol 11:1253–1263PubMedGoogle Scholar
  6. 6.
    Crawford AW, Ford I, Ozer H, Stoller R, et al. (1991) Reduction by granulocyte colony stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N Engl J Med 325:164–170PubMedGoogle Scholar
  7. 7.
    Antman KH (1994) pp 80–85Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • B. Thürlimann
    • 1
  1. 1.Department of Internal Medicine CDivision of Oncology/HaematologyKantonsspitalSt. GallenSwitzerland

Personalised recommendations